Limited Access
Please log in to myERS to view this content
Don't have a myERS account? Register here
Note: patients and members of the public are not permitted to view this content
Sanofi
This content has been provided by Sanofi Regeneron. The content is not influenced or endorsed by the European Respiratory Society
Understand how type 2 cytokines drive inflammatory patterns commonly seen in severe asthma, and how they can be characterised using existing biomarkers.